| Dr Tracy Elizabeth Wimbush, MD | |
|
1240 Eagles Landing Pkwy, Suite 300, Stockbridge, GA 30281 | |
| (770) 506-4350 | |
| (770) 506-9860 |
| Full Name | Dr Tracy Elizabeth Wimbush |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 24 Years |
| Location | 1240 Eagles Landing Pkwy, Stockbridge, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780669739 | NPI | - | NPPES |
| 003134595J | Medicaid | GA | |
| 2034247 | Medicaid | MA | |
| 468709 | Other | MA | TUFTS HEALTH PLAN |
| J27108 | Other | MA | BCBS MA |
| 003134595K | Medicaid | GA | |
| 003134595L | Medicaid | GA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Piedmont Henry Hospital | Stockbridge, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Piedmont Orthopedics, Llc | 4385963172 | 149 |
News Archive
Forest Laboratories, Inc. today announced that it has filed a response to the U.S. Food & Drug Administration (FDA) addressing topics raised in the complete response letter regarding the New Drug Application (NDA) for roflumilast. Forest licenses roflumilast from Nycomed, which submitted the original NDA.
In a new research paper currently available on the bioRxiv* preprint server, a research group from the United Kingdom (UK) provides experimental evidence that B.1.617 lineage of the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) – also known as the Indian variant of concern – shows enhanced cleavage of spike glycoprotein by furin, which can enhance its transmissibility and pathogenic traits.
A study conducted in the UK has examined attitudes towards vaccination protecting against COVID-19 and highlighted some of the main drivers of willingness or unwillingness to be immunized.
Sanofi Canada announces a new option for the emergency treatment of anaphylaxis. Allerject is the first and only 'talking' epinephrine auto-injector in Canada.
› Verified 2 days ago
| Entity Name | Orthoatlanta, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851937114 PECOS PAC ID: 3971406885 Enrollment ID: O20040129000005 |
News Archive
Forest Laboratories, Inc. today announced that it has filed a response to the U.S. Food & Drug Administration (FDA) addressing topics raised in the complete response letter regarding the New Drug Application (NDA) for roflumilast. Forest licenses roflumilast from Nycomed, which submitted the original NDA.
In a new research paper currently available on the bioRxiv* preprint server, a research group from the United Kingdom (UK) provides experimental evidence that B.1.617 lineage of the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) – also known as the Indian variant of concern – shows enhanced cleavage of spike glycoprotein by furin, which can enhance its transmissibility and pathogenic traits.
A study conducted in the UK has examined attitudes towards vaccination protecting against COVID-19 and highlighted some of the main drivers of willingness or unwillingness to be immunized.
Sanofi Canada announces a new option for the emergency treatment of anaphylaxis. Allerject is the first and only 'talking' epinephrine auto-injector in Canada.
› Verified 2 days ago
| Entity Name | Piedmont Orthopedics, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114317062 PECOS PAC ID: 4385963172 Enrollment ID: O20150429000361 |
News Archive
Forest Laboratories, Inc. today announced that it has filed a response to the U.S. Food & Drug Administration (FDA) addressing topics raised in the complete response letter regarding the New Drug Application (NDA) for roflumilast. Forest licenses roflumilast from Nycomed, which submitted the original NDA.
In a new research paper currently available on the bioRxiv* preprint server, a research group from the United Kingdom (UK) provides experimental evidence that B.1.617 lineage of the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) – also known as the Indian variant of concern – shows enhanced cleavage of spike glycoprotein by furin, which can enhance its transmissibility and pathogenic traits.
A study conducted in the UK has examined attitudes towards vaccination protecting against COVID-19 and highlighted some of the main drivers of willingness or unwillingness to be immunized.
Sanofi Canada announces a new option for the emergency treatment of anaphylaxis. Allerject is the first and only 'talking' epinephrine auto-injector in Canada.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tracy Elizabeth Wimbush, MD 900 Circle 75 Pkwy Se, Suite 1700, Atlanta, GA 30339-3035 Ph: (770) 953-6929 | Dr Tracy Elizabeth Wimbush, MD 1240 Eagles Landing Pkwy, Suite 300, Stockbridge, GA 30281 Ph: (770) 506-4350 |
News Archive
Forest Laboratories, Inc. today announced that it has filed a response to the U.S. Food & Drug Administration (FDA) addressing topics raised in the complete response letter regarding the New Drug Application (NDA) for roflumilast. Forest licenses roflumilast from Nycomed, which submitted the original NDA.
In a new research paper currently available on the bioRxiv* preprint server, a research group from the United Kingdom (UK) provides experimental evidence that B.1.617 lineage of the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) – also known as the Indian variant of concern – shows enhanced cleavage of spike glycoprotein by furin, which can enhance its transmissibility and pathogenic traits.
A study conducted in the UK has examined attitudes towards vaccination protecting against COVID-19 and highlighted some of the main drivers of willingness or unwillingness to be immunized.
Sanofi Canada announces a new option for the emergency treatment of anaphylaxis. Allerject is the first and only 'talking' epinephrine auto-injector in Canada.
› Verified 2 days ago
David A Burns, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1133 Eagles Landing Pkwy, Stockbridge, GA 30281 Phone: 678-604-1053 | |
Dr. Khalique U. Rehman, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 245 Village Center Pkwy, # 130, Stockbridge, GA 30281 Phone: 770-288-3311 Fax: 770-288-3824 | |
Dr. Chinonye Beverly Orizu, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1133 Eagles Landing Pkwy, Stockbridge, GA 30281 Phone: 678-604-1053 | |
Mr. Randall Charles Berinhout, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 165 N Park Trl, Suite 100, Stockbridge, GA 30281 Phone: 770-506-1800 Fax: 770-506-4686 |